azomycin has been researched along with clomipramine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billaut-Mulot, O; Fernandez-Gomez, R; Ouaissi, A | 1 |
| Baez, A; Bazán, PC; Cremonezzi, D; Esteves, B; Fauro, R; Lo Presti, MS; Paglini-Oliva, PA; Rivarola, HW; Sanchez Negrete, O; Strauss, M | 1 |
| Aoki, MP; García, MC; Jimenez-Kairuz, AF; Manzo, RH; Ponce, NE; Sanmarco, LM | 1 |
| Báez, AL; Bazán, PC; Bustamante, JM; Lo Presti, MS; Nakamura, CV; Paglini-Oliva, P; Rivarola, HW; Rodrigues, JHS; Strauss, M | 1 |
4 other study(ies) available for azomycin and clomipramine
| Article | Year |
|---|---|
Phenotype of recombinant Trypanosoma cruzi which overexpress elongation factor 1-gamma: possible involvement of EF-1gamma GST-like domain in the resistance to clomipramine.
Topics: Animals; Clomipramine; DNA, Complementary; Drug Resistance; Glutathione Transferase; Nifurtimox; Nitroimidazoles; Peptide Elongation Factor 1; Peptide Elongation Factors; Phenotype; Trypanocidal Agents; Trypanosoma cruzi | 1997 |
Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection.
Topics: Animals; Chagas Disease; Clomipramine; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Female; Intestines; Kidney; Liver; Male; Mice; Muscle, Skeletal; Myocardium; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
Topics: Animals; Chagas Disease; Clomipramine; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Synergism; Heart; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Parasitemia; Parasitic Sensitivity Tests; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2016 |
In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Topics: Animals; Chagas Disease; Clomipramine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Inhibitory Concentration 50; Male; Mice; Multivariate Analysis; Muscle, Skeletal; Myocardium; Nitroimidazoles; Parasitemia; Principal Component Analysis; Real-Time Polymerase Chain Reaction; Trypanocidal Agents; Trypanosoma cruzi | 2018 |